
### [NCIT:C4962](http://purl.obolibrary.org/obo/NCIT_C4962)
**Label:** Malignant Thymus Neoplasm

**Subclasses:** [NCIT:C35718](http://purl.obolibrary.org/obo/NCIT_C35718) (Thymic Undifferentiated Carcinoma), [NCIT:C7904](http://purl.obolibrary.org/obo/NCIT_C7904) (Invasive Malignant Thymoma), [NCIT:C6457](http://purl.obolibrary.org/obo/NCIT_C6457) (Thymic Mucoepidermoid Carcinoma), [NCIT:C8878](http://purl.obolibrary.org/obo/NCIT_C8878) (Stage III Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C8879](http://purl.obolibrary.org/obo/NCIT_C8879) (Stage IV Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C6459](http://purl.obolibrary.org/obo/NCIT_C6459) (Thymic Adenocarcinoma), [NCIT:C8876](http://purl.obolibrary.org/obo/NCIT_C8876) (Stage I Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C6458](http://purl.obolibrary.org/obo/NCIT_C6458) (Thymic Adenosquamous Carcinoma), [NCIT:C8877](http://purl.obolibrary.org/obo/NCIT_C8877) (Stage II Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C7569](http://purl.obolibrary.org/obo/NCIT_C7569) (Thymic Carcinoma), [NCIT:C8874](http://purl.obolibrary.org/obo/NCIT_C8874) (Recurrent Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C8875](http://purl.obolibrary.org/obo/NCIT_C8875) (Refractory Mediastinal (Thymic) Large B-Cell Cell Lymphoma), [NCIT:C6430](http://purl.obolibrary.org/obo/NCIT_C6430) (Thymic Carcinoid Tumor), [NCIT:C27937](http://purl.obolibrary.org/obo/NCIT_C27937) (Thymic Papillary Adenocarcinoma), [NCIT:C6455](http://purl.obolibrary.org/obo/NCIT_C6455) (Thymic Squamous Cell Carcinoma), [NCIT:C45722](http://purl.obolibrary.org/obo/NCIT_C45722) (Combined Thymic Epithelial Neoplasm), [NCIT:C6451](http://purl.obolibrary.org/obo/NCIT_C6451) (Thymic Lymphoma), [NCIT:C7905](http://purl.obolibrary.org/obo/NCIT_C7905) (Recurrent Malignant Thymoma), [NCIT:C6889](http://purl.obolibrary.org/obo/NCIT_C6889) (Malignant Type B2 Thymoma), [NCIT:C7612](http://purl.obolibrary.org/obo/NCIT_C7612) (Malignant Thymoma), [NCIT:C7997](http://purl.obolibrary.org/obo/NCIT_C7997) (Thymoma Type B3), [NCIT:C6886](http://purl.obolibrary.org/obo/NCIT_C6886) (Malignant Type AB Thymoma), [NCIT:C7996](http://purl.obolibrary.org/obo/NCIT_C7996) (Malignant Type B1 Thymoma), [NCIT:C7999](http://purl.obolibrary.org/obo/NCIT_C7999) (Malignant Type A Thymoma), [NCIT:C7998](http://purl.obolibrary.org/obo/NCIT_C7998) (Thymic Lymphoepithelioma-Like Carcinoma), [NCIT:C115444](http://purl.obolibrary.org/obo/NCIT_C115444) (Recurrent Combined Thymic Epithelial Neoplasm), [NCIT:C6463](http://purl.obolibrary.org/obo/NCIT_C6463) (Thymic Sarcomatoid Carcinoma), [NCIT:C6460](http://purl.obolibrary.org/obo/NCIT_C6460) (Thymic Small Cell Carcinoma), [NCIT:C6462](http://purl.obolibrary.org/obo/NCIT_C6462) (Thymic Clear Cell Carcinoma), [NCIT:C6461](http://purl.obolibrary.org/obo/NCIT_C6461) (Thymic Large Cell Neuroendocrine Carcinoma), [NCIT:C9280](http://purl.obolibrary.org/obo/NCIT_C9280) (Mediastinal (Thymic) Large B-Cell Lymphoma), [NCIT:C45719](http://purl.obolibrary.org/obo/NCIT_C45719) (Thymic Atypical Carcinoid Tumor), [NCIT:C9080](http://purl.obolibrary.org/obo/NCIT_C9080) (Noninvasive Malignant Thymoma), [NCIT:C95038](http://purl.obolibrary.org/obo/NCIT_C95038) (Thymoliposarcoma), [NCIT:C4903](http://purl.obolibrary.org/obo/NCIT_C4903) (Metastatic Malignant Neoplasm in the Thymus), 

**Class expressions from DL-Learner:**

- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C36116](http://purl.obolibrary.org/obo/NCIT_C36116) (Borderline Lesion))) 62.50%
- Thing 51.60%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) 47.86%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C40175](http://purl.obolibrary.org/obo/NCIT_C40175) (Uterine Corpus Myxoid Leiomyosarcoma))) 47.86%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C40174](http://purl.obolibrary.org/obo/NCIT_C40174) (Uterine Corpus Epithelioid Leiomyosarcoma))) 47.86%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C40170](http://purl.obolibrary.org/obo/NCIT_C40170) (Uterine Corpus Diffuse Leiomyomatosis))) 47.86%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C40168](http://purl.obolibrary.org/obo/NCIT_C40168) (Uterine Corpus Lipoleiomyoma))) 47.86%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C40167](http://purl.obolibrary.org/obo/NCIT_C40167) (Uterine Corpus Bizarre Leiomyoma))) 47.86%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C40166](http://purl.obolibrary.org/obo/NCIT_C40166) (Uterine Corpus Myxoid Leiomyoma))) 47.86%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C40165](http://purl.obolibrary.org/obo/NCIT_C40165) (Uterine Corpus Apoplectic Leiomyoma))) 47.86%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C40164](http://purl.obolibrary.org/obo/NCIT_C40164) (Uterine Corpus Epithelioid Leiomyoma))) 47.86%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C40163](http://purl.obolibrary.org/obo/NCIT_C40163) (Uterine Corpus Cellular Leiomyoma))) 47.86%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 47.86%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 47.86%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 47.86%


